Appendix 3B
Imagion Biosystems has announced “Appendix 3B, New issue announcement, application for quotation of additional securities and agreement.” Read Appendix 3B.
Imagion Biosystems has announced “Appendix 3B, New issue announcement, application for quotation of additional securities and agreement.” Read Appendix 3B.
Imagion Biosystems announces a pro-rata offer prospectus. Read the pro-rata offer prospectus.
Imagion Biosystems is pleased to announce a pro-rata renounceable rights issue (Offer) to fund the manufacture of the nanoparticle material, the undertaking of a first-in-human
Imagion Biosystems announces the presentation “MagSense® Imaging: Early Detection of Cancer Through Targeted Imaging.” See the presentation “MagSense® Imaging“.
Imagion Biosystems is pleased to provide an update on its progress and plans for manufacturing of its proprietary nanoparticle formulation in advance of the first
Imagion Biosystems has announced “Appendix 3B, New issue announcement, application for quotation of additional securities and agreement.” Read Appendix 3B.
MELBOURNE — Imagion Biosystems Limited (ASX: IBX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer, today announces appointments to
Imagion Biosystems Limited today announced “Appendix 3B New issue announcement, application for quotation of additional securities and agreement.” Read Appendix 3B.
Imagion Biosystems is pleased to provide an update on its capital management and progress towards its first-in-human study, Read the Investor Update.
Imagion Biosystems Limited has given notice under section 708A(5)(e) of the Corporations Act 2001. Read the notice.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance